•  
  •  
  •  
  •  

2025-10-03 15:15:34

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Black Box Partners with Wind River to Accelerate Edge and Cloud Innovation Globally
  • Godrej Properties ranked #1 amongst global residential developers for its ESG practices by GRESB
  • Union Minister Shri. Prahlad Joshi launches Refex Green Mobility Operations in Delhi NCR
  • IHC Expands Global Portfolio with USD 1Bn investment in Sammaan Capital
  • Revolt Motors Strengthens Leadership Team with Appointment of Raghava Rao as Chief Business Officer

Keywords Selected:  TentativeApproval

Stock Report

  • Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg
  • Lupin receives tentative approval from U.S. FDA for Oxcarbazepine ER Tablets
  • Zydus receives tentative approval from USFDA for Rifaximin Tablets, 550 mg
  • Lupin receives tentative approval from U.S. FDA for Amifampridine Tablets
  • Alembic Pharmaceuticals Ltd announces USFDA Tentative Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
  • Zydus receives tentative approval from USFDA for Enzalutamide Tablets, 40 mg and 80 mg
  • Gland Pharma receives Tentative Approval from the USFDA for Latanoprostene Bunod Ophthalmic Solution
  • Alembic Pharmaceuticals announces USFDA Tentative Approval for Selexipag for Injection, 1,800 mcg/vial
  • Zydus receives tentative approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg
  • Zydus receives tentative approval from USFDA for Azilsartan Medoxomil Tablets, 40 mg and 80 mg
  • Alembic Pharmaceuticals announces USFDA Tentative Approval for Ivosidenib Tablets 250 mg
  • Alembic Pharmaceuticals announces USFDA Tentative Approval for Bosutinib Tablets, 100 mg and 500 mg.
  • Zydus receives tentative approval from USFDA for Azilsartan Medoxomil and Chlorthalidone Tablets
  • Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets
  • Zydus receives tentative approval from USFDA for Letermovir Tablets, 240 mg and 480 mg
  • Zydus receives Tentative Approval from the USFDA for Edaravone Injection, 30 mg/100 mL (0.3 mg/mL), Single-Dose Vial
  • Zydus receives Tentative Approval from the USFDA for Dexamethasone Tablets USP, 1 mg
  • Lupin receives tentative approval from U.S. FDA for Rivaroxaban Tablets USP
  • Lupin receives tentative approval from U.S. FDA for Dapagliflozin and Saxagliptin Tablets
  • Lupin receives tentative approval from U.S. FDA for Sitagliptin Tablets
  • Zydus receives final approval from the USFDA for Darunavir Tablets 600 mg and 800 mg, and tentative approval for 75 mg and 150 mg tablets
  • Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets
  • Lupin receives tentative approval from U.S. FDA for Canagliflozin Tablets
  • Lupin receives tentative approval from U.S. FDA for Dapagliflozin Tablets

Latest Post

  • Black Box Partners with Wind River to Accelerate Edge and Cloud Innovation Globally
  • Godrej Properties ranked #1 amongst global residential developers for its ESG practices by GRESB
  • Union Minister Shri. Prahlad Joshi launches Refex Green Mobility Operations in Delhi NCR
  • IHC Expands Global Portfolio with USD 1Bn investment in Sammaan Capital
  • Revolt Motors Strengthens Leadership Team with Appointment of Raghava Rao as Chief Business Officer


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024